Reduced Expression of Galectin-8 May Contribute in Carcinogenic Pathway of Head and Neck Squamous Cell Carcinoma
Background & Objectives: Galectin-8 has relationships with cell growth and metastasis of some cancers. Due to controversy in the clinical significance of this protein in the cancer process, we investigated its roles in the development of head and neck squamous cell carcinoma. Methods: This study...
Saved in:
Main Authors: | Maryam Ghasemi (Author), Laleh Vahedi Larijani (Author), Jamshid azdani-Charati (Author), Elham Kamali Hakim (Author) |
---|---|
Format: | Book |
Published: |
Iranian Society of Pathology,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
by: Stefano Cavalieri, et al.
Published: (2021) -
Docetaxel in the treatment of squamous cell carcinoma of the head and neck
by: Alexander Rapidis, et al.
Published: (2008) -
MAPKs activation in head and neck squamous cell carcinomas
by: Daniele Maggioni, et al.
Published: (2011) -
Postoperative radiotherapy may not be necessary for locally advanced head and neck squamous cell carcinoma: a case-match multicentre study
by: Zhen-Hu Ren, et al.
Published: (2022) -
Bibliometric analysis of immunotherapy for head and neck squamous cell carcinoma
by: Xin-Jia Cai, et al.
Published: (2023)